Podcasts about cirm

Guest: Dr. Jonathan Thomas "JT" is the President and CEO of the California Institute for Regenerative Medicine (CIRM), an organization that provides funding for stem cell research with the purpose of accelerating treatments for patients in need. He talks about working to ensure diversity in clinical trials and developing treatments that are affordable and accessible to patients. He also discusses the progress during the twenty years since CIRM's inception, training the next generation of scientists, and balancing support for basic and clinical research. (41:03) Featured Products and Resources: Register now for ISSCR 2025 in Hong Kong! Cell Quality Attributes of Human Pluripotent Stem Cells The Stem Cell Science Round Up Regulating Naive Pluripotency – Scientists used a targeted rapid protein degradation system to show that GABPA is a master pluripotency regulator. (1:36) Skin Wound Healing – A spatiotemporal atlas of human skin wound tissues identifies FOSL1 as a critical driver of re-epithelialization. (11:50) Bone Marrow Stem Cell Niches – The bone marrow niche orchestrates hierarchy in stem cells and immune tolerance. (20:49) Synthetic Organizer Cells – Synthetic organizer cells self-assemble around stem cells and produce morphogens. (30:50) Image courtesy of Dr. Jonathan Thomas Subscribe to our newsletter! Never miss updates about new episodes. Subscribe

Greetings! As usual, I'm offering up a veritible cornucopia of interesting music, from brand new items to older classics and not so classic. I had no planned thematic agenda, but assembled the sets so that they made sense to me. I hope they do the same for you. Enjoy! Joel e-mail: pushingtheenvelopewhus@gmail.com Blue Sky: https://bsky.app/profile/envpusher1.bsky.social  Twiter-like x-thing: https://twitter.com/envpusher1      12-7-24 PTE Playlist   Salting Black Ice / Cold Ovens / Snow and a Dovecote - Delta Saxophone Quartet / mezzo soprano: Frances Gregory / piano, composer: Paul Honey / poetry: Gregory Warren Wilson - Songs of Ice and Snow - FMR Records (2024) https://deltasaxophonequartet1.bandcamp.com/album/songs-of-ice-and-snow    Arndale (Part 1) / Arndale (Part 2) / Arndale (Part 3) GM Bus 184 - david a jaycock - Music for Space Age Shopping - Subexotic Records (2024) https://davidajaycock.bandcamp.com/album/music-for-space-age-shopping    Adhesion (excerpt) - Freight Cell (Fletina) - Adhesion - fletinamusic (2024) https://freightcell.bandcamp.com/album/adhesion    Mvmt.1 /Mvmt.2/Mvmt.3 - DVXNS - Cuarteto Latinoamericano / composer: Dan Roman - DVXNS - Neuma Records (2024) https://danroman.bandcamp.com/album/dvxns    In paradisium (Black lipstick) - piano and sound collage: Joe Frawley - Speak of This To No One - Clinical Archives (2010) https://archive.org/details/ca405_jf    Avanti La Tre - Piero Milesi - Within Himself (Music for Films, Installations, Water & Fireworks) - Cuneiform Records (2000) https://cuneiformrecords.bandcamp.com/album/within-himself-music-for-films-installations-water-and-fireworks-1987-1999    3 - ~2 / rp7 - chebi - RO PAX (2024) https://ro-pax.bandcamp.com/album/cheby-2-rp7    Photogrammes - ORCHESTRE DE L'AGORA / conductor: Nicolas Ellis / composer: Alexandre David - Photogrammes - COLLECTION QB (2024) https://collectionqb.bandcamp.com/album/alexandre-david-photogrammes    Line 752 - Chronochromie - Epoch - digital release (2023) https://chronochromie.bandcamp.com/album/epoch    Uses Probe Form, w/ Shawn Persinger is Prester John - Doctor Nerve - LOUD - Punos Music (2019) https://www.punosmusic.com/doctornerve/loud/    "Halloween Baptizm" Suite -Shawn Persinger is Prester John - Halloween Baptizm - Quixotic Music (2017) https://presterjohnmusic.com/halloween/    Larks' Tongues In Aspic, Part II (2023 Elemental Mix) - King Crimson - Larks' Tongues In Aspic (The Complete Recording Sessions) - Discipline Global Mobile (2023) https://www.dgmlive.com/    Rowl kreditz - CIRM (ts-erm) - 1​/​40MVoaT - digital release (2024) https://cirm.bandcamp.com/album/1-40mvoat    Confessions - Zbigniew Seiffert - Solo Violin - Zbigniew Seiffert Foundation (1978) 

Ron Crabtree and Joe Lynch discuss Supply Chain 2030. Ron is the Founder and CEO of MetaOps & MetaExperts, a global network of operational excellence rockstars ready to tackle your toughest challenges. They'll diagnose your problems and get you back on track, fast. Summary: Supply Chain 2030 In this podcast, Joe Lynch and Ron Crabtree delve into the critical challenges and trends shaping the future of the supply chain industry. They discuss the importance of digitalization, automation, and AI readiness in transforming supply chain operations. The podcast also explores the impending labor shortage crisis and the need for organizations to focus on lean techniques, automation, and becoming an employer of choice. Additionally, the role of social responsibility in supply chains and the importance of technology in ensuring visibility and adherence to standards are addressed. The podcast provides valuable insights from both shipper and logistics service provider perspectives, and highlights the solutions offered by Meta Ops and Meta Experts in solving complex supply chain challenges. #TMSAElevate2023 #SupplyChainChallenges #EmployerOfChoice About Ron Crabtree Ron, CIRM, MLSSBB,CSCTA, CPOE is the founder and CEO (2002) of MetaOps™ & MetaExperts™Inc. he is an internationally recognized expert in leading-edge business process improvement methodologies. He is a Master Lean Six Sigma Black Belt, a Certified Supply Chain Transformation Architect and also an expert in effective change management, facilitation and communications. Ron draws on more than 30 years' experience in implementing Lean, Six Sigma, Supply Chain and other “best practice” methodologies as both an insider and as a consultant in many international industries including insurance & financial services, state/local government, medical/healthcare, automotive assembly plants, complex manufacturing, process manufacturing, repair operations, printing, injection molding, consumer goods, distribution/retailing, and software and more. About MetaExperts MetaExperts is a global network of Operational Excellence (OpEx) deployment experts and resources for flexible, on-demand short-term contract or contract-to-hire needs. MetaExperts align with industries and OpEx initiatives and are thoroughly vetted through their unique 300+ Screening and Evaluation Processes, and aligned to organizations using a 47+ alignment process to ensure companies get the right talent to solve their specific situation. Key Takeaways: Supply Chain 2030 Learn about the major operational challenges facing the supply chain industry over the next 5-6 years. Discover how Meta Ops and Meta Experts provide top talent solutions for tangible goods-oriented organizations. Understand the importance of long-term consulting projects in providing insights from both shipper and logistics service provider perspectives. Explore how companies can address the numerous challenges in digitalization and automation within the supply chain industry. Recognize the growing significance of social responsibility and the role of technology in ensuring supplier adherence to standards. Learn strategies for organizations to combat the forever labor shortage, including lean techniques, automation, and becoming an employer of choice. Timestamps (00:00:44) Supply Chain Challenges of the Future (00:01:43) Solving Big Business Problems with Expertise (00:03:07) Consulting Projects: Short-Term to Long-Term Engagements (00:05:16) Solving Supply Chain Challenges with Experts (00:08:49) Leveraging Experienced Talent in Supply Chain (00:17:07) Navigating the Digital Transformation Landscape (00:24:04) ESG Practices and Technology Challenges (00:25:22) Navigating ESG and Supply Chain Responsibility (00:29:17) Navigating Digital Transformation in Supply Chain (00:33:02) The Forever Labor Shortage (00:36:58) Combating the Forever Labor Shortage (00:43:05) Meaningful Work Matters Most (00:45:30) Lean Manufacturing and Supply Chain Shifts (00:50:16) Adapting to the Changing Workforce Landscape (00:52:33) Preparing for Supply Chain's Future Challenges (00:56:55) Diagnosing and Solving Supply Chain Problems (00:59:30) Engaging with Supply Chain Leaders Learn More About Supply Chain 2030 Ron Crabtree | Linkedin MetaExperts | Linkedin MetaExperts MetaPod Driving Operational Excellence Book Episode Sponsor: TMSA TMSA - Transportation Marketing & Sales Association TMSA ELEVATE - Transportation Marketing & Sales Summit Building a Freight Sales & Marketing Community | The Logistics of Logistics Episode Sponsor: Revenova Contact Us | Revenova The CRM-Powered TMS with Michael Horvath | The Logistics of Logistics The Logistics of Logistics Podcast If you enjoy the podcast, please leave a positive review, subscribe, and share it with your friends and colleagues. The Logistics of Logistics Podcast: Google, Apple, Castbox, Spotify, Stitcher, PlayerFM, Tunein, Podbean, Owltail, Libsyn, Overcast Check out The Logistics of Logistics on Youtube

At #ASGCT2024, Dr. Lam (CIRM) spoke during a symposium on developing CGTs with a DEI-forward approach. In this interview, she talks about  incorporating DEI into the review criteria for CIRM's funded programs, how to measure DEI, and what she'd like to see in the long term for patients. Meeting registrants can watch this session (and all others) through June 21 on the virtual platform and the app! Host: Lynnea Olivarez, incoming Communications Commmittee ChairShow your support for ASGCT!: https://asgct.org/membership/donateSee omnystudio.com/listener for privacy information.

En este episodio abordaremos el Mensaje que los Obispos de México estuvieron preparando durante las últimas semanas: Por una educación integral, para todos, de calidad y verdaderamente humana. Lo anterior, con motivo de las respectivas festividades de este mes: Día de las Madres y de los Maestros, así como el contexto histórico que le acompaña, marcado por la gran contienda electoral. Nos acompañarán agentes de primer nivel, representando a distintas instituciones del País: la Confederación Nacional de Escuelas Particulares, la Unión Nacional de Padres de Familia, la COPARMEX, la AMIESIC, la Red de Educación de la CIRM, la Federación Empresarial Humanista, Enfoque Noticias, así como la Vicaría Episcopal de Laicos en el Mundo de la Arquidiócesis Primada de México. Dialogue con nosotros a través de las redes sociales y le pedimos nos ayude a difundir, si así le parece conveniente.

Menopause expert, Dr. Mary Claire Haver, a board-certified OB/GYN and certified menopause specialist joins Dr. Stephanie in this episode. From debunking fallacies from the Women's Health Initiative to discussing various hormone therapy options, including estrogen, progesterone, and different delivery methods, this episode equips listeners with essential knowledge. Whether you're experiencing perimenopausal symptoms or contemplating hormone therapy as a preventative measure, Dr. Haver provides valuable insights and actionable tips.This episode will give you a comprehensive understanding of menopause hormone therapy and empower yourself or the women you love with the information needed to make informed decisions about their health.Episode Overview:0:00 Teaser/Intro1:22 Signs of Perimenopause3:00 In-Depth Symptom Analysis11:08 Evolutionary Advantages of Menopause18:45 Menopause Hormone Therapy30:01 Hormone Therapy Benefits in Menopause36:34 Hormone Therapy Considerations for Menopausal Women40:11 CIRM as an Option44:07 Missed the Menopause Boat47:40 Magnesium: The Forgotten Nutrient51:17 Prioritize Good Nutrition55:36 Protein-Centric Approach1:01:37 Family History: No Disqualifications1:04:22 Avoid Injury with Weight Training1:06:52 Hormone Therapy Side Effects1:09:00 Future of Menopause TherapyResources mentioned in the episode:Dr. Haver's new book - https://thepauselife.com/en-ca/pages/the-new-menopause-bookEpisode on Women's Health Initiative - https://drstephanieestima.com/podcasts/hrt-bioidenticals-menopause-benefits-risks/How Does Menopause Change Your Brain? A Deep Dive with Dr. Lisa Mosconi - https://drstephanieestima.com/podcasts/how-does-menopause-change-your-brain-a-deep-dive/https://www.menopause.orghttps://www.felixforyou.ca/ailment/menopauseBio:Dr. Mary Claire Haver is board certified in Obstetrics and Gynecology and is a Certified Culinary Medicine Specialist from Tulane University. She is a Louisiana State University Medical Center graduate and completed her Obstetrics and Gynecology residency at the University of Texas Medical Branch (UTMB). She is also a Certified Menopause Specialist through The Menopause Society.  Find out more at https://thepauselife.com/ and Instagram - https://www.instagram.com/drmaryclaire/We are grateful to our sponsors:SUNLIGHTENI am incredibly bullish on sauna as a therapy for recovery, heart health, and overall aging well. It's crucial for hormonal balance and achieving a state of well-being necessary for a strong physique and a strong mind. Visit https://www.sunlighten.com/BETTER/?utm_source=DrStephanieEstima&utm_medium=Partner&leadsource=DrStephanieEstima&utm_campaign=DrStephanieEstima and use code BETTER to get a discount.EQUIP FOODSYou can use this grass-fed collagen daily, to take care of your hair, skin, nails, joints, and gut after resistance training workouts, or you can even bake with it because it tastes like dessert, not beef. Go to https://equipfoods.com/better and use the code BETTER for 20% off. ONESKINIt's time for a radical shift in skin care. This year I am doubling down on skin health and OneSkin is one of the ways I am getting my 40-year-old skin to behave like 20-year-old skin. Visit https://www.oneskin.co/?utm_source=partner&utm_medium=podcast&utm_campaign=BETTER and use the code BETTER at checkout to save 15%.

CIRM-funded Alpha Stem Cell Clinics are a network of California medical centers that specialize in delivering stem cell clinical trials to patients. In this fascinating panel, clinic directors discuss advanced treatments, therapies like gene editing, and sharing knowledge and creating networks across the country for better patient care. Featuring: Geoffrey Lomax, Dr.PH California Institute for Regenerative Medicine Esther and Andrew Schorr Patient Advocates Sandra Dillon Cancer Survivor and Stem Cell Champion Catriona Jamieson, M.D., Ph.D. UC San Diego Mehrdad Abedi, M.D. UC Davis Daniela A. Bota, M.D., Ph.D. UC Irvine Sheila Chari, Ph.D. Cell Press Leo D. Wang, M.D., Ph.D. City of Hope National Medical Center Mark Walters, M.D. University of California, San Francisco Thomas Buchanan, M.D. University of Southern California Michael Lewis, M.D. Cedars Sinai Noah Federman, M.D. UCLA Series: "Stem Cell Channel" [Health and Medicine] [Show ID: 39070]

CIRM-funded Alpha Stem Cell Clinics are a network of California medical centers that specialize in delivering stem cell clinical trials to patients. In this fascinating panel, clinic directors discuss advanced treatments, therapies like gene editing, and sharing knowledge and creating networks across the country for better patient care. Featuring: Geoffrey Lomax, Dr.PH California Institute for Regenerative Medicine Esther and Andrew Schorr Patient Advocates Sandra Dillon Cancer Survivor and Stem Cell Champion Catriona Jamieson, M.D., Ph.D. UC San Diego Mehrdad Abedi, M.D. UC Davis Daniela A. Bota, M.D., Ph.D. UC Irvine Sheila Chari, Ph.D. Cell Press Leo D. Wang, M.D., Ph.D. City of Hope National Medical Center Mark Walters, M.D. University of California, San Francisco Thomas Buchanan, M.D. University of Southern California Michael Lewis, M.D. Cedars Sinai Noah Federman, M.D. UCLA Series: "Stem Cell Channel" [Health and Medicine] [Show ID: 39070]

CIRM-funded Alpha Stem Cell Clinics are a network of California medical centers that specialize in delivering stem cell clinical trials to patients. In this fascinating panel, clinic directors discuss advanced treatments, therapies like gene editing, and sharing knowledge and creating networks across the country for better patient care. Featuring: Geoffrey Lomax, Dr.PH California Institute for Regenerative Medicine Esther and Andrew Schorr Patient Advocates Sandra Dillon Cancer Survivor and Stem Cell Champion Catriona Jamieson, M.D., Ph.D. UC San Diego Mehrdad Abedi, M.D. UC Davis Daniela A. Bota, M.D., Ph.D. UC Irvine Sheila Chari, Ph.D. Cell Press Leo D. Wang, M.D., Ph.D. City of Hope National Medical Center Mark Walters, M.D. University of California, San Francisco Thomas Buchanan, M.D. University of Southern California Michael Lewis, M.D. Cedars Sinai Noah Federman, M.D. UCLA Series: "Stem Cell Channel" [Health and Medicine] [Show ID: 39070]

CIRM-funded Alpha Stem Cell Clinics are a network of California medical centers that specialize in delivering stem cell clinical trials to patients. In this fascinating panel, clinic directors discuss advanced treatments, therapies like gene editing, and sharing knowledge and creating networks across the country for better patient care. Featuring: Geoffrey Lomax, Dr.PH California Institute for Regenerative Medicine Esther and Andrew Schorr Patient Advocates Sandra Dillon Cancer Survivor and Stem Cell Champion Catriona Jamieson, M.D., Ph.D. UC San Diego Mehrdad Abedi, M.D. UC Davis Daniela A. Bota, M.D., Ph.D. UC Irvine Sheila Chari, Ph.D. Cell Press Leo D. Wang, M.D., Ph.D. City of Hope National Medical Center Mark Walters, M.D. University of California, San Francisco Thomas Buchanan, M.D. University of Southern California Michael Lewis, M.D. Cedars Sinai Noah Federman, M.D. UCLA Series: "Stem Cell Channel" [Health and Medicine] [Show ID: 39070]

CIRM-funded Alpha Stem Cell Clinics are a network of California medical centers that specialize in delivering stem cell clinical trials to patients. In this fascinating panel, clinic directors discuss advanced treatments, therapies like gene editing, and sharing knowledge and creating networks across the country for better patient care. Featuring: Geoffrey Lomax, Dr.PH California Institute for Regenerative Medicine Esther and Andrew Schorr Patient Advocates Sandra Dillon Cancer Survivor and Stem Cell Champion Catriona Jamieson, M.D., Ph.D. UC San Diego Mehrdad Abedi, M.D. UC Davis Daniela A. Bota, M.D., Ph.D. UC Irvine Sheila Chari, Ph.D. Cell Press Leo D. Wang, M.D., Ph.D. City of Hope National Medical Center Mark Walters, M.D. University of California, San Francisco Thomas Buchanan, M.D. University of Southern California Michael Lewis, M.D. Cedars Sinai Noah Federman, M.D. UCLA Series: "Stem Cell Channel" [Health and Medicine] [Show ID: 39070]

Clive Svendsen, Ph.D., leads groundbreaking experiments using stem cell transplants, uncovering unexpected findings. These trials aimed at improving ALS treatments, revealed higher success with upper motor neuron transplants compared to spinal cord methods. Svendsen's exploration of cortical transplants hints at a potential breakthrough. Moreover, his study of stem cell behavior in space opens doors to exciting medical advancements. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 39068]

Clive Svendsen, Ph.D., leads groundbreaking experiments using stem cell transplants, uncovering unexpected findings. These trials aimed at improving ALS treatments, revealed higher success with upper motor neuron transplants compared to spinal cord methods. Svendsen's exploration of cortical transplants hints at a potential breakthrough. Moreover, his study of stem cell behavior in space opens doors to exciting medical advancements. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 39068]

Clive Svendsen, Ph.D., leads groundbreaking experiments using stem cell transplants, uncovering unexpected findings. These trials aimed at improving ALS treatments, revealed higher success with upper motor neuron transplants compared to spinal cord methods. Svendsen's exploration of cortical transplants hints at a potential breakthrough. Moreover, his study of stem cell behavior in space opens doors to exciting medical advancements. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 39068]

Clive Svendsen, Ph.D., leads groundbreaking experiments using stem cell transplants, uncovering unexpected findings. These trials aimed at improving ALS treatments, revealed higher success with upper motor neuron transplants compared to spinal cord methods. Svendsen's exploration of cortical transplants hints at a potential breakthrough. Moreover, his study of stem cell behavior in space opens doors to exciting medical advancements. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 39068]

Clive Svendsen, Ph.D., leads groundbreaking experiments using stem cell transplants, uncovering unexpected findings. These trials aimed at improving ALS treatments, revealed higher success with upper motor neuron transplants compared to spinal cord methods. Svendsen's exploration of cortical transplants hints at a potential breakthrough. Moreover, his study of stem cell behavior in space opens doors to exciting medical advancements. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 39068]

Clive Svendsen, Ph.D., leads groundbreaking experiments using stem cell transplants, uncovering unexpected findings. These trials aimed at improving ALS treatments, revealed higher success with upper motor neuron transplants compared to spinal cord methods. Svendsen's exploration of cortical transplants hints at a potential breakthrough. Moreover, his study of stem cell behavior in space opens doors to exciting medical advancements. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 39068]

Clive Svendsen, Ph.D., leads groundbreaking experiments using stem cell transplants, uncovering unexpected findings. These trials aimed at improving ALS treatments, revealed higher success with upper motor neuron transplants compared to spinal cord methods. Svendsen's exploration of cortical transplants hints at a potential breakthrough. Moreover, his study of stem cell behavior in space opens doors to exciting medical advancements. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 39068]

Dr. Mark DeWitt Ph.D., Associate Director at Mammoth Biosciences, and Dr. Don Kohn M.D., distinguished professor and Director of the UCLA Human Gene and Cell Therapy Program and CIRM grantee sat down with us to discuss their latest clinical trials to cure sickle cell anemia, how synthetic guides accelerated their journey from the bench to the clinic, and their experience in the cell and gene therapy space.

Share this episode: https://www.samharris.org/podcasts/making-sense-episodes/337-the-future-of-psychedelic-medicine Sam Harris speaks with Jeannie Fontana and Robin Carhart-Harris about the TREAT Initiative in California and the growing promise of psychedelics for mental health care. Jeannie Fontana, MD, PhD, is a multifaceted leader in healthcare, specializing in Internal Medicine, Environmental Toxicology, and Biochemistry and Molecular Biophysics. She initiated an ALS-focused research team at Sanford Burnham Prebys and established the Cedars-Sinai ALS Center of Excellence, driving policy change and boosting federal funding for ALS research. As a founding trustee of the California Institute for Regenerative Medicine (CIRM), she played a pivotal role in creating the world's largest stem cell granting agency with an $8.5 billion budget. Under her influence, the agency has achieved FDA approvals, fast-track designations, and launched groundbreaking clinical trials. Additionally, CIRM catalyzed the creation of over 55,000 jobs, 50 new companies, and $10 billion in added state revenue. Now, Jeannie is poised to address California's urgent mental health crisis through her role in the TREAT California Initiative. Website: treatcalifornia.org Robin Carhart-Harris, PhD, moved to Imperial College London in 2008 after obtaining a PhD in Psychopharmacology from the University of Bristol. He has designed human brain imaging studies with LSD, psilocybin, MDMA and DMT, and several clinical trials of psilocybin therapy for severe mental illnesses, including 3 key trials in depression plus 2 further trials in anorexia and fibromyalgia syndrome. Dr Carhart-Harris founded the Centre for Psychedelic Research at Imperial College London in April 2019, the first of its kind in the world. In 2020, he was named among the top 31 medical scientists by The Times newspaper. Dr Carhart-Harris became the inaugural Ralph Metzner Distinguished Professor of Neurology and Psychiatry at the University of California San Francisco in 2021, and in the same year, was listed in TIME magazine’s ‘100 Next’ - a list of emerging leaders from around the world who are shaping the future. Website: carhartharrislab.com Twitter: @RCarhartHarris Learning how to train your mind is the single greatest investment you can make in life. That’s why Sam Harris created the Waking Up app. From rational mindfulness practice to lessons on some of life’s most important topics, join Sam as he demystifies the practice of meditation and explores the theory behind it.

David Steven Jacoby is a well-known expert in the global supply chain. He is changing the supply chain game. He has written make books on the topic, which you will find in his Bio below. To learn more about David, visit these websites: http://www.supplychainification.com/ (COMING SOON) https://bostonstrategies.com/ https://davidstevenjacoby.com/ BIO David is the President of Boston Strategies International, a consultancy that helps energy companies and national governments develop strategic value chains for critical materials, components, and equipment to achieve superior profitability and energy independence. He is teaches Operations Management and Supply Chain Management at New York University's Tandon School of Engineering and is a Senior Fellow at Boston University's Institute for Global Sustainability, as well as a former adjunct professor at Boston University's Questrom Graduate School of Business. He wrote Guide to Supply Chain Management for The Economist, Reinventing the Energy Value Chain for PennWell Books, and four other books on supply chain management and international trade. He earned his MBA and a Masters of Arts from the Wharton School at the University of Pennsylvania, and his academic and professional contributions to the field of supply chain management span hundreds of publications and media events. He holds supply chain certifications including C.P.M. CTL, CIRM, CFPM, CSCP, and AEE. He has served as an advisory board member at New York Energy Week and a Chief Judge at the International Supply Chain Educational Association and was previously an international management consultant at Kearney and Oliver Wyman in the United States, France, Brazil, Hong Kong, and elsewhere. David is passionate about building businesses that transform global supply chains. Based on extensive management experience in energy, automotive, transport, and retail in more than 50 countries managing and advising executive leadership teams, he has deep and practical first-hand knowledge of what's on the other end of your international supply chain and how you can use that information to reduce cost, grow revenue, and increase shareholder value. To learn more about David, please visit https://davidstevenjacoby.com/

Healthcare and medicine have long served as a hotbed of innovation. Perhaps the leading edge these days requires a paradigm shift – think digital therapeutics, Web3, the metaverse, CRISPR, Software as a Medical Device – this is the domain of Neil Littman, Founder & CEO of Bioverge, a highly curated impact-investment venture platform exclusively dedicated to healthcare and to democratizing access to investing in early stage companies and startups. The Bioverge platform serves as a decentralized network linking capital to potential investment opportunities. Neil also hosts, The Bioverge Podcast. Neil talked about his time at the California Institute for Regenerative Medicine and what it was like from both the scientific and business aspects. It was there that he learned that the institutional model of financing and investing could be applied to the retail sector as well. Combining those experiences and what he learned firsthand, lead to his creating the Bioverge platform. Neil discussed that the decentralized network he built provides warm referrals to Bioverge with the goal of linking capital for potential investment opportunities. But they also provide value added services beyond just capital that helps founders and portfolio companies that may need support and expertise along the way. Beyond sourcing deal flow, they conduct due diligence on the investment opportunities by leveraging their network of subject matter experts who also have deep domain expertise. Neil's work is such a great example of “doing well while doing good” by helping to save lives and change the world.

CIRM-funded Alpha Stem Cell Clinics are a network California medical centers that specialize in delivering stem cell clinical trials to patients. Sandra Dillon shares how their work has impacted treatments for her rare cancer. Maria T. Millan, M.D., Mehrdad Abedi, M.D., Daniela A. Bota, M.D., Ph.D., Sheila Chari, Ph.D., Noah Federman, M.D., Catriona Jamieson, M.D., Ph.D., Sean Turbeville, Ph.D., and Leo D. Wang, M.D., Ph.D., then discuss current clinical trials and the future of stem cell research. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 38400]

CIRM-funded Alpha Stem Cell Clinics are a network California medical centers that specialize in delivering stem cell clinical trials to patients. Sandra Dillon shares how their work has impacted treatments for her rare cancer. Maria T. Millan, M.D., Mehrdad Abedi, M.D., Daniela A. Bota, M.D., Ph.D., Sheila Chari, Ph.D., Noah Federman, M.D., Catriona Jamieson, M.D., Ph.D., Sean Turbeville, Ph.D., and Leo D. Wang, M.D., Ph.D., then discuss current clinical trials and the future of stem cell research. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 38400]

CIRM-funded Alpha Stem Cell Clinics are a network of California medical centers that specialize in delivering stem cell clinical trials to patients. Sandra Dillon shares how their work has impacted treatments for her rare cancer. Maria T. Millan, M.D., Mehrdad Abedi, M.D., Daniela A. Bota, M.D., Ph.D., Sheila Chari, Ph.D., Noah Federman, M.D., Catriona Jamieson, M.D., Ph.D., Sean Turbeville, Ph.D., and Leo D. Wang, M.D., Ph.D., discuss current clinical trials and the future of stem cell research. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 38400]

CIRM-funded Alpha Stem Cell Clinics are a network of California medical centers that specialize in delivering stem cell clinical trials to patients. Sandra Dillon shares how their work has impacted treatments for her rare cancer. Maria T. Millan, M.D., Mehrdad Abedi, M.D., Daniela A. Bota, M.D., Ph.D., Sheila Chari, Ph.D., Noah Federman, M.D., Catriona Jamieson, M.D., Ph.D., Sean Turbeville, Ph.D., and Leo D. Wang, M.D., Ph.D., discuss current clinical trials and the future of stem cell research. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 38400]

CIRM-funded Alpha Stem Cell Clinics are a network of California medical centers that specialize in delivering stem cell clinical trials to patients. Sandra Dillon shares how their work has impacted treatments for her rare cancer. Maria T. Millan, M.D., Mehrdad Abedi, M.D., Daniela A. Bota, M.D., Ph.D., Sheila Chari, Ph.D., Noah Federman, M.D., Catriona Jamieson, M.D., Ph.D., Sean Turbeville, Ph.D., and Leo D. Wang, M.D., Ph.D., discuss current clinical trials and the future of stem cell research. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 38400]

CIRM-funded Alpha Stem Cell Clinics are a network of California medical centers that specialize in delivering stem cell clinical trials to patients. Sandra Dillon shares how their work has impacted treatments for her rare cancer. Maria T. Millan, M.D., Mehrdad Abedi, M.D., Daniela A. Bota, M.D., Ph.D., Sheila Chari, Ph.D., Noah Federman, M.D., Catriona Jamieson, M.D., Ph.D., Sean Turbeville, Ph.D., and Leo D. Wang, M.D., Ph.D., discuss current clinical trials and the future of stem cell research. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 38400]

CIRM-funded Alpha Stem Cell Clinics are a network of California medical centers that specialize in delivering stem cell clinical trials to patients. Sandra Dillon shares how their work has impacted treatments for her rare cancer. Maria T. Millan, M.D., Mehrdad Abedi, M.D., Daniela A. Bota, M.D., Ph.D., Sheila Chari, Ph.D., Noah Federman, M.D., Catriona Jamieson, M.D., Ph.D., Sean Turbeville, Ph.D., and Leo D. Wang, M.D., Ph.D., discuss current clinical trials and the future of stem cell research. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 38400]

In the next installment of ASTCT's Titans of Transplant series, Dr. John. F. DiPersio, an internationally recognized leader in hematopoietic stem cell transplantation and acute leukemia and past president of ASTCT (2019) is interviewed by Dr. Roman Shapiro. About Dr. John F. DiPersio John F. DiPersio, MD, PhD is deputy director at Alvin J. Siteman Cancer Center, director at Center for Gene and Cellular Immunotherapy and chief of the division of oncology at Washington University School of Medicine in St. Louis and the Virginia E. and Samuel J. Golman professor of medicine. His research focuses on mechanistic and translational aspects of leukemia and stem cell biology. He has played a key role in the clinical development of plerixafor as a mobilizing agent for stem cell transplantation. DiPersio has played a key leadership role in the team-science work at Washington University that has defined the genetic and epigenetic factors that contribute to clonal evolution and relapse in AML. He has served in leadership roles for the American Society of Hematology (ASH), multiple NIH, CIRM, LLS, and CPRIT Study Sections, and has served on NCI's Board of Scientific Counselors. He is an elected member of ASCI and AAP, and past president of the American Society of Transplantation and Cellular Therapy (2019). About Dr. Roman Shapiro Roman Shapiro, MD is a physician working with the bone marrow transplantation group at the Dana-Farber Cancer Institute. His main clinical and academic interest is the prevention and treatment of malignant disease following stem cell transplant. His contributions to science include optimizing the use of natural killer (NK) cell therapy, including cytokine-induced memory-like (CIML) NK cells, for the prevention and treatment of post-transplant relapse of myeloid disease. The Titans of Transplant series seeks to recognize, celebrate and chronicle the physicians, researchers, pharmacists, nurses, social workers and more who were on the frontlines of the early days of transplant.

Mabuhay and Welcome, dear listeners of Filipina on the Rise… While Krystl takes a much deserved break, you'll hear a new voice on the podcast. Hi! I'm Tesz Millan, Creator of the YouTube series Filipina. American. Creative. For my very first episode hosting this amazing podcast, I brought in the support of someone I've looked up to and admired, pretty much my entire life. Dr. Maria T. Millan, MD is the President and CEO of CIRM, the California Institute for Regenerative Medicine. As the leader of this groundbreaking organization, she is leading its mission to help direct 8.5 billion dollars toward stem cell research projects and clinical trials that are not only saving lives but changing the way the world heals its sickest patients. Before that, she was the Director of Pediatric Transplantation at Stanford University, and before that, she completed her Surgery Residency at Harvard. Simply put, she is a bad a$$. Most importantly, she's an amazing Filipina, a mom of two college students, loving wife to her husband David, and yes, she is my cousin! In this episode we'll cover…·       How to shed the armor of over-achieving that prevents us from having real, meaningful connections·       Maria's journey of becoming a pediatric surgeon of the highest degree, to leading CIRM as CEO and President, to being a mother and the importance of embracing vulnerability and trusting yourself along the way·       Knowing when enough is enough - that what you do is good enough·       How Filipino culture upholds positional hierarchy and the affect it can have on our need to constantly overwork ·       What play looks like and how to learn the art of play from those around youImportance of Episode:Culturally, as Filipinas and as immigrants, we feel the pressure of wanting to fit in and have a place. We're brought up and even rewarded to achieve in order to feel like we bring value to this world. Making the mistake of thinking ONLY our achievements make us worthy can be detrimental to our overall mental health and physical well-being. To stay healthy, it's essential to recognize when enough is enough, to not beat yourself up when you take time to play/rest, and to know you have a place even when you're not in service all. the. time. Embrace vulnerability, take care of yourself and learn to forgive yourself for being human. Taking a moment for you to be "selfish" is not going to define you forever. It will actually help make you stronger and more whole, so you can fully give your best self to the world.Watch Exclusive Footage from My First Interview with Maria: https://youtu.be/gpuTByvPTmcConnect with Maria: * LinkedIn: https://www.linkedin.com/in/maria-t-millan-m-d-4438b06/ Join the Filipina Soul Sisterhood Circle! Hang out with Krystl and other “journeying” Pinays every week, as we reconnect with our culture, meet with and get mentored by impactful, industry-disrupting Filipina leaders, and help each other step into our power as Pinays.Support, Share, Follow, Get Spotlighted:·       Support the show for as little as $1 a month: http://patreon.com/filipinaontherise·       Follow IG @filipinaontherisePledge $3 or $10 a month to help keep the show going! Here: Patreon

CEM convoca a ‘Jornada de Oración por la Paz’.

Alfonso estudió matemáticas en la UNAM, en la Université d'Orsay y en Oxford University. Durante su carrera ha visitado y expuesto su trabajo en diversas instituciones tales como UCLA, Universität Münster, Notre Dame University, Institute Henri Poincaré, IHES, CIRM, Sophus Lie Conference Centre, CIMAT, University of Miami entre otros. Actualmente es Director del Colegio de Matemáticas Bourbaki y dedica su tiempo a convertirlo en un centro de enseñanza e investigación de primer nivel. Este podcast es presentado por X-DATA, el estudio de análisis y visualización de datos más efectivo en México, es el manual que necesitas para potenciar tus negocios y proyectos a través de los datos. Learn more about your ad choices. Visit megaphone.fm/adchoices

Alpha Stem Cell Clinics are a network of clinics providing stem cell clinical trials to patients. Directors of these clinics throughout the state of California share what the future of these trials looks like, what the future holds for alpha clinics, funding for research, and patient impacts. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 37560]

Alpha Stem Cell Clinics are a network of clinics providing stem cell clinical trials to patients. Directors of these clinics throughout the state of California share what the future of these trials looks like, what the future holds for alpha clinics, funding for research, and patient impacts. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 37560]

Alpha Stem Cell Clinics are a network of clinics providing stem cell clinical trials to patients. Directors of these clinics throughout the state of California share what the future of these trials looks like, what the future holds for alpha clinics, funding for research, and patient impacts. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 37560]

Alpha Stem Cell Clinics are a network of clinics providing stem cell clinical trials to patients. Directors of these clinics throughout the state of California share what the future of these trials looks like, what the future holds for alpha clinics, funding for research, and patient impacts. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 37560]

Alpha Stem Cell Clinics are a network of clinics providing stem cell clinical trials to patients. Directors of these clinics throughout the state of California share what the future of these trials looks like, what the future holds for alpha clinics, funding for research, and patient impacts. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 37560]

Alpha Stem Cell Clinics are a network of clinics providing stem cell clinical trials to patients. Directors of these clinics throughout the state of California share what the future of these trials looks like, what the future holds for alpha clinics, funding for research, and patient impacts. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 37560]

Alpha Stem Cell Clinics are a network of clinics providing stem cell clinical trials to patients. Directors of these clinics throughout the state of California share what the future of these trials looks like, what the future holds for alpha clinics, funding for research, and patient impacts. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 37560]

30 năm kể từ khi giành được độc lập, 5 quốc gia Trung Á vẫn thuộc vùng ảnh hưởng của Nga. Trong khuôn khổ dự án Một vành đai một con đường, Bắc Kinh dùng thương mại, đầu tư và kể cả quân sự để chen chân vào Kazakhstan, Kirghizistan, Ouzbekistan, Tadjikistan, Turkmenistan vốn được coi là sân sau của nước Nga. Vùng đất giàu tài nguyên này trở thành cái gai trong quan hệ hữu hảo giữa Nga và Trung Quốc ? Tháng 10/2021, Douchanbé thông báo cho phép Trung Quốc xây dựng một căn cứ quân sự tại biên giới giữa Tadjikistan với Afghanistan. Sự kiện này làm dấy lên nghi vấn xung khắc lợi ích giữa Nga và Trung Quốc tại một khu vực mang tính chiến lược cao mà cả Mỹ lần Liên Hiệp Châu Âu cùng không mấy quan tâm.   Năm 2017 chủ tịch Trung Quốc Tập Cận Bình long trọng tiếp đón các nguyên thủ quốc gia và thủ tướng chính phủ tại Bắc Kinh chung quanh dự án Một vành đai một con đường kết nối Trung Quốc với năm châu. Nhân dịp này tổng thống Nga, Vladimir Putin đã đọc một bài diễn văn quan trọng ủng hộ sáng kiến của Bắc Kinh « tạo đà mới cho các hoạt động mậu dịch của các nước Trung Á », mắt xích không thể thiếu trong dự án của ông Tập Cận Bình. Giới quan sát ngạc nhiên trước tuyên bố nói trên của chủ nhân điện Kremlin bởi đầu tư và Con Đường Tơ Lụa mới của Trung Quốc có nguy cơ thu hẹp ảnh hưởng của nước Nga tại Trung Á. Kazakhstan, Kirghizistan, Ouzbekistan, Tadjikistan, Turkmenistan trải rộng trên diện tích 4 triệu km2, với chưa đầy 70 triệu dân cư. Ouzbekistan là quốc gia lớn nhất chiếm tới 2/3 diện tích của toàn khối 5 nước Trung Á này, một vùng kẹt giữa Iran, Nga và Trung Quốc chịu ảnh hưởng về văn hóa của Thổ Nhĩ Kỳ (4 trong số 5 quốc gia trong vùng nói tiếng Thổ). Từ thập niên 1920/1930 Trung Á đặt dưới vòng kềm tỏa của Liên Xô và đã giành được độc lập vào năm 1991 khi chế độ cộng sản Xô Viết sụp đổ. Matxcơva luôn xem 5 nước Trung Á là « một mắt xích chiến lược » về « an ninh và đối ngoại ».    Trả lời đài truyền hình Pháp France 24 nhà nghiên cứu Michael Levystone, Viện Quan hệ Quốc Tế Pháp IFRI, tác giả cuốn sách mang tên Nga và Trung Á trước một sự lựa chọn lựa -NXB L'Harmattan, giải thích về tầm quan hệ đặc biệt lâu đời của Nga với từng nước khu vực này :   « Có nhiều cách tiếp cận khác nhau : Kazakhstan là một đối tác kinh tế không thể thiếu của Nga tại Trung Á. Noursoultan cũng là một đối tác về năng lượng dưới nhiều khía cạnh : Kazakhstan vừa là một trạm trung chuyển dầu khí của Nga, vừa là một đối tác then chốt trong lĩnh vực năng lượng hạt nhân. Thêm vào đó, với căn cứ không gian Baikonour, Kazakhstan và Nga hợp tác chặt chẽ trong lĩnh vực không gian. Ngoài Kazakhstan, thì Ouzbekistan và Turkmenistan tỏ ra thận trọng với Nga. Tuy nhiên Matxcơva đang khởi động lại quan hệ với hai đối tác này : với Ouzbekistan là từ 2016 còn với Turkmenistan là từ 2018. Riêng trong trường hợp của Kirghizistan và Tadjikistan, đối thoại chủ yếu liên quan đến vế an ninh đặc biệt là trong tình hình bấp bệnh tại Afghanistan hiện nay ».  Nga không giàu như Trung Quốc Từ khi Liên Xô tan rã, Matxcơva luôn đưa ra những sáng kiến để « giữ » Trung Á trong tầm ảnh hưởng của mình như việc thành lập Liên Minh Kinh Tế Á Âu năm 2014 hay trước đó năm 2002 qua Tổ Chức Hiệp Ước An Ninh Tập Thể CSTO. Nga vẫn duy trì căn cứ quân sự trên lãnh thổ Kirghizistan và Tadjikistan đồng thời vẫn còn ít nhất hai đơn vị thường trực của quân đội Nga đồn trú tại Kirghizistan. Về mặt kinh tế, các tập đoàn dầu khí của Nga vẫn « kiểm soát một phần lớn các khâu khai thác, lọc và chuyên chở đưa năng lượng cảu Trung Á đến thị trường châu Âu »    Tuy nhiên thực tế không thể chối cãi là Matxcơva không có phương tiện tài chính hấp dẫn như Trung Quốc. Kazakhstan, Ouzbekistan và Turkmenistan có nhiều dự trữ về dầu khí cần được khai thác, trong lúc quặng mỏ, khoáng sản là những điểm mạnh để Kirghizistan và Tadjikistan thu hút đầu tư Trung Quốc.  Trong bài nghiên cứu đăng trên trang mạng tạp chí Areion.news tháng 1/2020, giáo sư Olga V. Alexeeva đại học Quebec UQAM và giám đốc khoa địa chính trị đại học Laval của Canada, Frédéric Lasserre ghi nhận : những nỗ lực của Nga nhằm duy trì đối thoại với các nước Trung Á từng thuộc Liên Xô cũ chỉ « hành công nửa vời » do Matxcơva eo hẹp về tài chính. Về phía Bắc Kinh, từ 2001 Trung Quốc đã bắt đầu quan tâm đến các quốc gia giàu tài nguyên này. 2001 cũng là thời điểm Tổ Chức Hợp Tác Thượng Hải ra đời và đó là điểm khởi của nhiều dự án đầu tư Trung Quốc vào Trung Á từ xây dựng đường ống dẫn dầu đến đập thủy điện hay hệ thống xa lộ. Hợp tác toàn diện với Trung Quốc Năm 2001, Trung Quốc chiếm 3 % tổng trao đổi mậu dịch của toàn khối 5 quốc gia Trung Á này. Năm 2013 khi ông Tập Cận Bình lên cầm quyền, tỷ lệ đó đã chiếm đến 25 %. Trong mắt nhà nghiên cứu Niva Yau, thuộc Tổ Chức An Ninh và Hợp Tác Châu Âu- OSCE, dự án Một vành đai một con đường là một bước ngoặt trong quan hệ giữa Bắc Kinh với Trung Á. Trong thập niên cuối thế kỷ XX, đầu tư Trung Quốc tập trung vào các công trình xây đường ống dẫn khí đốt của Turkmenistan, vào công nghiệp khai thác dầu của Kazakhstan và hệ thống cầu đường tại Kirghizistan, hay Tadjikistan. Từ 2013 trở đi các chương trình đầu tư của Trung Quốc mang tính toàn diện hơn theo mô hình BOT –Build-Operate-Transfer : mà ở đó kỹ sư Trung Quốc thiết kế công xưởng, đào tạo người lao động địa phương, khai thác nhà máy trong ít nhất 5 năm trước khi trao lại chìa khóa cho nước chủ nhà. Với những dự án này, Trung Quốc làm chủ từ các nhà máy phân bón của Kirghizistan đến ngành công nghiệp luyện kim của Kazakhstan…   Nhà nghiên cứu Michael Levystone viện IFRI đánh giá về hiệu quả của đầu tư Trung Quốc vào Trung Á :    « Đối với Trung Á, những hiệu quả tích cực rõ ràng được trông thấy ngay lập tức. Đó là công luận chú ý đến một khu vực bị gạt ra bên lề tiến trình toàn cầu hóa. Đây là nơi không có thị trường chứng khoán, không có cửa ngõ ra biển trong lúc phần lớn giao thương quốc tế là bằng đường hàng hải. Thoạt đầu Nga, tuy không trực tiếp nói ra nhưng không có thiện cảm với dự án con đường tơ lụa mới của Trung Quốc. Nhưng rồi, Matxcơva cho ra đời Liên Minh Kinh Tế Á Âu năm 2014, với Kazakhstan, Kirghizistan, Ouzbekistan đã thúc đẩy tiến trình hội nhập. Kế tới, Tadjikistan cũng xin gia nhập khối này. Năm 2015 một thỏa thuận giữa Liên Minh Kinh Tế Á Âu với con đường tơ lụa mới được ký kết và đây là hậu quả từ sau đợt phương Tây trừng phạt Nga xâm chiếm bán đảo Cirmée của Ukraina, đồng thời tố cáo Matxcơva gây bất ổn ở miền đông Ukraina. Nga tập trung nhiều hơn vào sườn đông, trong đó có Trung Quốc và các nước Trung Á. Đđó là một cột mốc quan trọng trong chính sách đối ngoại của Kremlin ».  Michael Levystone, tác giả cuốn Nga và Trung Á trước một sự lựa chọn giải thích thêm : với những mức độ khác nhau, Trung Á đã dễ dàng mở rộng vòng tay với Trung Quốc.    « Trung Quốc trở thành đối tác thương mại quan trọng nhất của hầu hết các nước Trung Á, ngoại trừ Kazakhstan. Bắc Kinh cũng là nguồn đầu tư lớn nhất vào khu vực vốn được xem là sân sau của Nga. Trung Quốc đứng dầu trong số các nhà đầu tư nước ngoài đầu tư vào Turkmenistan, Tadjikistan và Kirghizistan. Nhưng đối với Ouzbekistan và Kazakhstan thì Nga vẫn là điểm tựa quan trọng nhất. Bắc Kinh chủ yếu đầu tư vào cơ sở hạ tầng tại các quốc gia trong vùng và tiêu biểu nhất là qua các dự án xây dựng đường ống dẫn dầu và khí đốt, đưa thẳng năng lượng khai thác từ Turkmenistan, hay Kazakhstan đến tận Hoa Lục ».   Hệ quả về chiến lược ? Trong trường hợp của Tadjikistan chẳng hạn quốc gia này có biên giới chung 400 cây số với Trung Quốc, Douchanbé bật đèn xanh cho Trung Quốc xây dựng căn cứ quân sự. Trung Quốc là bạn hàng và là nhà đầu tư quan trọng nhất của Tadjikistan. Hơn thế nữa Bắc Kinh nắm giữ hơn một nửa tổng số nợ của chính chính quyền Douchanbé.  Còn đối với Matxcơva, hơn một triệu người lao động Tadjikistan làm việc tại Nga và số này gửi tiền về nước giúp đỡ gia đình. Khoản ngoại tệ đó tương đương với 1/3 GDP của Tadjikistan. Những con số nói trên cho thấy, Trung Á bị chịu ảnh hưởng rất lớn của cả phía Nga lẫn Trung Quốc.   Câu hỏi kế tiếp là ảnh hưởng kinh tế lớn mạnh Trung Quốc kéo theo những hậu quả nào về phương diện địa chính trị ? Hai nhà nghiên cứu Canada, Alexeeva và Lasserre trên mạng Areion 24.news cho rằng Bắc Kinh và Matxcơva cùng muốn bảo đảm vùng Trung Á được ổn định. Bắc Kinh bác bỏ mọi ý đồ lấy đầu tư và thương mại để cạnh tranh thậm chí là qua  mặt Matxcơva nhưng rõ ràng là Nga không có phương tiện như Trung Quốc. Kremlin đứng trước một thách thức mới mang tên Một vành đai một con đường. Tuy nhiên như chuyên gia Pháp, Michael Levystone vừa phân tích, dưới sức ép của các biện pháp trừng phạt phương Tây ban hành Matxcơva đã chọn giải pháp xích lại gần với Bắc Kinh. Kremlin kỳ vọng Nga cũng thu hút được nhiều đầu tư Trung Quốc. Tuy nhiên trước mắt Bắc Kinh mới chỉ chú trọng vào một vài lĩnh vực như dầu khí của Nga, dự án khai thác tuyến đường biển đi ngang qua Bắc Cực hay dự án đường xe lửa xuyên Siberie để đưa hàng Trung Quốc sang châu Âu và trong chiều ngược lại đưa dầu khí của Nga vào lãnh thổ Trung Quốc. Có điều như hai đồng tác giả bài tham luận mang tựa đề Trung Á, tâm điểm hiềm khích bá chủ của Nga và Trung Quốc đăng trên mạng Areion24.news tháng 1/2020, trước mắt Bắc Kinh chậm thông báo giải ngân các dự án đầu tư hàng tỷ đô la vào Nga để thực hiện các công trình nói trên. Từ sau thông báo năm 2015 , nối nhịp cầu giữa Con Đường Tơ Lụa Mới và Liên Minh Kinh Tế Á Âu, sau bài diễn văn gây chú ý của tổng thống Putin tại Bắc Kinh năm 2017, đối thoại Bắc Kinh-Matxcơva về hợp tác tại Trung Á ít có tiến triển cụ thể. Điều đó cho thấy không một bên nào dễ nhượng bộ bởi vì lợi ích cả về kinh tế, chiến lược cùng quá lớn.

En nouvelle diffusion: La vie en montagne en période de changement climatique Pour mieux savoir ce que signifie vivre en montagne dans un contexte de changement climatique, les chercheurs du Centre interdisciplinaire de recherche sur la montagne (CIRM) et le Service de médiation scientifique de lʹUniversité de Lausanne (Unil) ont élaboré un projet de sciences participatives dans le Val dʹHérens. Sarah Dirren a participé à lʹune des activités: le comptage d'arbres du côté dʹArolla. Avec Christophe Randin, chercheur en biogéographie à l'Unil et directeur du Jardin alpin de Champex et du Centre alpin de phytogéographie (CAP), Séverine Trouilloud, médiatrice scientifique à lʹEprouvette, le laboratoire public de l'Unil, et Lucienne Roh, responsable de la communication et de la médiation scientifique au Jardin alpin de Champex. Visiter l'univers en 3D Bastien Confino vous propose de visiter lʹUnivers en 3D. Cette expérience proposée par lʹEcole polytechnique fédérale de Lausanne (EPFL) permet notamment aux astrophysiciens de mieux appréhender leurs données. Avec Hadrien Gurnel, informaticien au Laboratoire de muséologie expérimentale de lʹEPFL, Jean-Paul Kneib, professeur dʹastrophysique à lʹEPFL, et Yves Revaz, maître d'enseignement et de recherche au Laboratoire d'astrophysique de lʹEPFL.

Pour mieux savoir ce que signifie vivre en montagne dans un contexte de changement climatique, les chercheurs du Centre interdisciplinaire de recherche sur la montagne (CIRM) et le Service de médiation scientifique de lʹUniversité de Lausanne (Unil) ont élaboré un projet de sciences participatives dans le Val dʹHérens. Sarah Dirren a participé à lʹune des activités: le comptage d'arbres du côté dʹArolla. Avec Christophe Randin, chercheur en biogéographie à l'Unil et directeur du Jardin alpin de Champex et du Centre alpin de phytogéographie (CAP), Séverine Trouilloud, médiatrice scientifique à lʹEprouvette, le laboratoire public de l'Unil, et Lucienne Roh, responsable de la communication et de la médiation scientifique au Jardin alpin de Champex.

Nos arrière-petits-enfants ne pourront plus admirer ce qui fait aujourdʹhui la carte postale helvétique. Sur les 1400 glaciers que compte encore la Suisse, seuls 50 subsisteront dʹici la fin du siècle en très haute altitude. La fonte des glaciers génère des risques concrets: problèmes dʹapprovisionnement en eau, en électricité et risques dʹéboulis plus fréquents. Mais elle nous force aussi à redéfinir notre lien affectif, identitaire et patrimonial à ces symboles du territoire alpin. Des espaces mal connus et effrayants il y a encore deux siècles, créateurs de tourisme et sources de revenus au XXème siècle et désormais marqueurs visibles du changement climatique. 5 reportages de Cécile Guérin Réalisation: Samuel Morier-Genoud Production: Laurence Difélix Invité.e.s: Mélanie Hugon-Duc Anthropologue et conservatrice au Musée de Bagnes & Emmanuel Reynard Professeur de géographie à lʹInstitut de géographie et durabilité de lʹUNIL et directeur du Centre interdisciplinaire de recherche sur la montagne (CIRM)

Dr. Maria Millan, MD, is the President and CEO of the California Institute for Regenerative Medicine (CIRM - https://www.cirm.ca.gov/), an organization that was created in 2004 when voters initially approved a state Proposition which allocated US$3 billion to fund this fascinating area of medicine, and which recently received an additional US$5.5 billion in renewed funding. Dr. Millan is a physician-scientist who has devoted her career to treating and developing innovative solutions for children and adults with debilitating and life-threatening conditions. After receiving her undergraduate degree from Duke University where she started her focus on immunology research, Dr. Millan obtained her MD degree and then went on to complete her surgical training and post-doctoral research at Harvard Medical School – Beth Israel Deaconess Medical Center. After a transplant surgery fellowship at Stanford University School of Medicine, Dr. Millan began her academic career with a pediatric and adult transplant surgery practice. In parallel, she continued her bench research at Stanford and became associate professor and director of the Pediatric Organ Transplant Program. Dr. Millan served on multiple leadership teams including the Faculty Senate and the Dean's faculty committee at Stanford University School of Medicine and served on the Children's Hospital operations committee. She has published in the areas of cell biology, immunology and clinical organ transplantation. Dr. Millan also ventured into the private sector in 2006 to join StemCells, Inc., one of the earliest stem cell organizations and the first to enter into an FDA-regulated clinical trial with a stem cell treatment for children with a fatal neurodegenerative disease. Dr. Millan then joined CIRM in December 2012 where she led the formation of the Alpha Stem Cell Clinics Network, a network of California medical centers that specialize in rigorous and high-quality clinical trials and top-tier medical care for patients participating in these trials. This clinical network is successfully supporting over 45 clinical trials and was recently expanded to include 5 programs composed of 7 medical centers and their affiliated hospitals.

Pauta:1)      O QUE ESPERAR DO PRIMEIRO ENCONTRO ENTRE BIDEN E PUTIN2)      DISPUTAS HEGEMONICAS: O sequestro de uma aeronave pela Bielorussia. Minuta do novo Livro Branco de Defesa Japonês irrita Pequim3)      BALANÇO DA PANDEMIA: Seguimos preocupados com a Índia e seu entorno, Argentina bate recordes e Paraguai interrompe vacinação. 4)      ESTAMOS DE OLHO: Crise entre ISRAEL e os PALESTINOS; Conflitos na Colômbia; .   5)      BOAS NOTÍCIAS: Criado no âmbito da CIRM, um Grupo Técnico para discutir os interesses do Brasil no Ártico. 

Small businesses and small business owners are something to celebrate! This week is Small Business Week in Dalton, and we are excited to celebrate Dalton's finest businesses, entrepreneurs, and those who support them.Check out our daily podcasts, created to keep you entertained, informed, and educated on small businesses here in your hometown, and how you can best support them. INTERVIEW WITH MARILYN M HELMS, D.B.A., CFPIM, CIRM, CSCP, CLTD, CQM/OE

In November, voters approved a new $5.5 billion bond measure that extends the life of the California Institute for Regenerative Medicine. The measure passed with far less fanfare than the original proposition that established the institute in the midst of a national controversy over embryonic stem cell research. With the passage of the new measure, the institute is expanding its work in emerging areas of regenerative medicine including cell and gene therapies and increasing its focus on translational research and clinical development. We spoke to Jonathan Thomas, chairman of the Independent Citizens' Oversight Committee, which oversees the California Institute for Regenerative Medicine, about the progress CIRM has made to date, what the new funding will enable, and how the institute hopes to help shape the future of regenerative medicine.